Categories: News

Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024

BELGRADE, MO / ACCESSWIRE / May 8, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended March 31, 2024, after the close of the financial markets on Wednesday, May 15, 2024.

Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference call on Wednesday, May 15 at 4:30 PM ET to review results.

Conference Details:
Conference Date: Wednesday, May 15, 2024
Conference Time: 4:30 PM ET
Conference dial-in: 877-545-0523
International dial-in: 973-528-0016
Passcode: 693614
Conference Call Name: Xtant Medical Q1 2024 Financial Results
Webcast Link: https://www.webcaster4.com/Webcast/Page/3039/50597

Following the live call, a replay will be available on the Company’s website, https://xtantmedical.com/, under “Investor Info.”

About Xtant Medical Holdings, Inc.

Xtant Medical’s mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (https://xtantmedical.com/) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

The symbols™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.

Investor Relations Contact

Brett Maas • Managing Partner, Hayden IR
brett@haydenir.com • (646) 536-7331

SOURCE: Xtant Medical Holdings, Inc.

View the original press release on accesswire.com

Staff

Recent Posts

Jorie AI Introduces Clinically Driven Predictive Analytics to Support Proactive Care and Revenue Performance

Hospital-specific predictive analytics designed to identify risk earlier, improve outcomes, and significantly reduce costs SAN…

3 hours ago

diaTribe Convenes International Consensus to Guide Diabetes Technology Use During Pregnancy

Expert recommendations provide crucial guidance to leverage CGM and AID during pregnancy.SAN FRANCISCO, Jan. 12,…

6 hours ago

diaTribe Convenes International Consensus to Guide Diabetes Technology Use During Pregnancy

Expert recommendations provide crucial guidance to leverage CGM and AID during pregnancy.SAN FRANCISCO, Jan. 12,…

6 hours ago

Luxury Medspa Brand ALEXIS LAUREN Announces Franchise Expansion Led by Founder Alexis Renda

Female-Founded Brand Looks to Expand Nationwide in High-Growth Aesthetic Wellness CategoryMIAMI, Jan. 12, 2026 /PRNewswire/…

6 hours ago

Luxury Medspa Brand ALEXIS LAUREN Announces Franchise Expansion Led by Founder Alexis Renda

Female-Founded Brand Looks to Expand Nationwide in High-Growth Aesthetic Wellness CategoryMIAMI, Jan. 12, 2026 /PRNewswire/…

6 hours ago

Health-E Commerce®, WEX, Inc. Team Up to Simplify Tax-free Flexible Spending Accounts (FSAs) and Health Saving Accounts (HSAs) Accounts for Consumers and Employers

Collaboration allows WEX and Health E-Commerce® to deliver a frictionless user experience to increase FSA/HSA…

6 hours ago